ESC

This channel contains news about the European Society of Cardiology (ESC), including coverage of its annual meeting and new guidelines. ESC is a leading resource for cardiology science and information in Europe.

A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is linked with stress and depression

News | Computed Tomography (CT)

Fully-automated One-click On-site CT-FFR: a Novel Tool for Functional Evaluation for Patients with Coronary Artery Disease

May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...

May 01, 2024

Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024, a scientific congress of the European Society of Cardiology (ESC)

News | Womens Cardiovascular Health

Women with Heart Disease Less Likely to Receive Life-saving Drugs than Men

April 29, 2024 — Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to ...

April 29, 2024

A new technology using ultralow temperature cryoablation (ULTC), developed by Adagio Medical, has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science was presented this week during EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).

News | ESC

Cryocure-VT Trial Outcomes Presented in EHRA 2024 Late-Breaking Science Session

April 10, 2024 — A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular ...

April 10, 2024

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.

News | ESC

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

April 10, 2024 — An international consensus statement on how to treat atrial fibrillation with catheter or surgical ...

April 10, 2024

BIOTRONIK, a leader in implantable medical device technology, announced today they will solely supply their proprietary DX models for new single-chamber ICD implants moving forward

News | Implantable Cardioverter Defibrillator (ICD)

The Future of Single Chamber ICDs: BIOTRONIK Takes Unprecedented Market Stance with Proprietary DX Technology

February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...

February 12, 2024

The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient.

News | Cardiovascular Clinical Studies

Trial to Prevent Sudden Death After a Heart Attack Enrolls First Patient

November 22, 2023 — The first clinical trial to challenge the routine implantation of a defibrillator in myocardial ...

November 22, 2023

University Hospitals Harrington Heart & Vascular Institute first to adopt technology in U.S.

News | Cath Lab

New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

September 13, 2023

Results from Two Phase 3 studies evaluating CAMZYOS (mavacamten) for symptomatic obstructive hypertrophic cardiomyopathy (HCM) were recently released by Bristol Myers Squibb.

News | Cardiovascular Clinical Studies

Results from Two Phase 3 Studies Evaluating Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Released

September 5, 2023 — New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-in ...

September 05, 2023

News | Cardiac Diagnostics

Wireless Handheld Ultrasound Device Launched by GE HealthCare for Rapid Assessment of Cardiac and Vascular Patients

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

September 05, 2023

CASTLE-HTx trial presented in a Hot Line session at ESC Congress 2023

News | Atrial Fibrillation

Atrial Fibrillation Ablation Improves Outcomes in Patients with End-stage Heart Failure

August 31, 2023 — Atrial fibrillation ablation is associated with lower rates of death, urgent heart transplantation or ...

August 31, 2023

ECLS-SHOCK trial presented in a Hot Line session at ESC Congress 2023

News | Cardiovascular Clinical Studies

ECLS-SHOCK Trial Reports Mortality Data for Extracorporeal Life Support

August 31, 2023 — Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial ...

August 31, 2023

This is the first international guideline document to include all cardiomyopathy subtypes

News | Congenital Heart

First International Guidelines on Heart Muscle Diseases Published

August 31, 2023 — The European Society of Cardiology (ESC) Guidelines on cardiomyopathies are published online in Europe ...

August 31, 2023

Non-inferiority and safety of one-month DAPT with BIOTRONIK’s drug-eluting stent presented as late-breaker at ESC 2023

News | Cardiovascular Clinical Studies

12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT

August 30, 2023 — BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ...

August 30, 2023

MULTISTARS AMI trial presented in a Hot Line session today at ESC Congress 2023

News | Cardiovascular Clinical Studies

Trial Investigates Timing of Complete Revascularization for Myocardial Infarction

August 30, 2023 — Immediate multivessel percutaneous coronary intervention (PCI) is non-inferior to staged multivessel ...

August 30, 2023

News | Heart Failure

Highlights from the ESC Congress 2023

August 30, 2023 — “Joining forces to protect the heart – this was our mission for this year’s ESC Congress,” said ...

August 30, 2023